Duration of bite force reduction following a single injection of botulinum toxin in the masseter muscle bilaterally: A one‐year non‐randomized trial
Journal of Oral Rehabilitation · 2023-05 · 50 (5) · 343-350
DOI: 10.1111/joor.13434 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Oral Rehabilitation, online erschienen am 02.03.2023. Verfasst von Martin Ågren und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Odontology, Faculty of Medicine, Umeå University, Umeå, Sweden. Hauptthemen laut MEDLINE: Neuromuscular Agents, Botulinum Toxins, Type A. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Merz Pharmaceuticals, Umeå University, Umeå Universitet.
Abstract (Originalsprache)
Background
Previous studies concerning the effect of botulinum toxin in masseter muscle have mainly reported effects observed through inspection of facial features or differences in pain levels. One systematic review of studies utilizing objective measurements reported that long‐term muscular effect of botulinum neurotoxin injections into masseter muscle was inconclusive.
Objective
To evaluate the duration of reduced maximal voluntary bite force (MVBF) after botulinum toxin intervention.
Methods
The intervention group was comprised of individuals seeking aesthetic treatment for masseter reduction ( n = 20), the reference group ( n = 12) comprised of individuals with no intervention. Intervention through 25 units of Xeomin® (Merz Pharma GmbH & Co KGaA, Frankfurt am Main, Germany) botulinum neurotoxin type A injected into the masseter muscles bilaterally (totalling 50 units). A reference group did not receive any intervention. MVBF was measured in Newtons using a strain gauge meter at the incisors and first molars. MVBF was measured at baseline, at 4 weeks, 3 months, 6 months, and after 1 year.
Results
Both groups were similar in terms of bite force, sex and age at baseline. MVBF remained similar compared to baseline in the reference group. At 3 months, a significant reduction at all measurement points was observed in the intervention group; at 6 months, this reduction was no longer significant.
Conclusion
A single intervention of 50 units of botulinum neurotoxin results in a reversible MVBF reduction of at least 3 months, although a visually discernable reduction may be more long‐lasting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Odontology, Faculty of Medicine, Umeå University, Umeå, Sweden.
- Prosthodontic Specialist Clinic, Region Västerbotten, Umeå, Sweden.
- Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
- Innovative Skin & Laser Surgery (iSKY) Center, Bangkok, Thailand.
ORCID-Profile: Martin Ågren, Yanisorn Nanchaipruek, Chalermkwan Apinuntham, Mattias Pettersson, Rungsima Wanitphakdeedecha
Förderung
- Merz Pharmaceuticals
- Umeå University
- Umeå Universitet
Zitieren
APA
Ågren, M., Nanchaipruek, Y., Phumariyapong, P., Apinuntham, C., Rakchart, S., Pettersson, M., & Wanitphakdeedecha, R. (2023). Duration of bite force reduction following a single injection of botulinum toxin in the masseter muscle bilaterally: A one‐year non‐randomized trial. Journal of Oral Rehabilitation, 50(5), 343-350. https://doi.org/10.1111/joor.13434
Vancouver
Ågren M, Nanchaipruek Y, Phumariyapong P, Apinuntham C, Rakchart S, Pettersson M, et al. Duration of bite force reduction following a single injection of botulinum toxin in the masseter muscle bilaterally: A one‐year non‐randomized trial. Journal of Oral Rehabilitation. 2023;50(5):343-350. doi:10.1111/joor.13434
BibTeX
@article{gren2023,
author = {Ågren, Martin and Nanchaipruek, Yanisorn and Phumariyapong, Phumithep and Apinuntham, Chalermkwan and Rakchart, Sarawalai and Pettersson, Mattias and Wanitphakdeedecha, Rungsima},
title = {Duration of bite force reduction following a single injection of botulinum toxin in the masseter muscle bilaterally: A one‐year non‐randomized trial},
journal = {Journal of Oral Rehabilitation},
year = {2023},
volume = {50},
number = {5},
pages = {343--350},
doi = {10.1111/joor.13434}
}
EUVIMED